The Cuproptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Immune Cell Infiltration in Hepatocellular Carcinoma

Figure 6

The group diagram of principal component analysis (PCA). (a) The whole gene expression in hepatocellular carcinoma (HCC) patients in two high- and low-risk groups; (b) the expression of cuproptosis genes; (c) the expression of cuproptosis-related long noncoding RNAs (LncRNAs); and (d) the expression of signature long noncoding RNAs(LncRNAs) for model construction.

(a)

(b)

(c)

(d)